AQCG Organises One-Day Track at PharmaLab 2025
Recommendation

Thursday, 3 September 2026 9 .00 - 17.00 h
Establishment, Use and Maintenance of Analytical Reference Substances
PharmaLab Congress, the event for all pharmaceutical laboratory sectors, will take place for the 13th time from 24–26 November 2025 – on site in Düsseldorf/Neuss. The PharmaLab 2025 conferences will cover a broad range of topics and lectures in analytics, bioanalytics and microbiology.
This year, the ECA Analytical Quality Control Group (AQCG) will organise a one-day conference track titled “Analytical Quality and Lifecycle Concepts”. Chaired by Dr Christopher Burgess (AQCG Chairman), the track will feature a series of presentations and discussions covering:
- The new AQCG Guidance Document on Sampling and Sample Management
- Lifecycle-based approaches to analytical instrument and procedure qualification (USP <1058>, <1225>, <1030>, <1033>)
- Implementation strategies for ICH Q2(R2) and Q14
- AQbD principles and their application in analytical method development
- Ongoing Procedure Performance Verification (USP <1221>)
- Good Documentation Practices and Data Integrity (USP <1229>)
The draft programme has just been published. To find out more about the programme, please visit the PharmaLab 2025 website.
Related GMP News
01.07.2026Several FDA Warning Letters and Untitled Letters on Asbestos Testing of Talc in OTC Drug Products
24.06.2026Analytical Quality Group Developments January through April 2026
17.06.2026BioPhorum Publishes a Roadmap for QC Sample Test Execution
03.06.2026EMA Provides an Outlook on the Product-Specific Bioequivalence Guidelines Expected in 2026
03.06.2026FDA Warning Letter: Missing Method Validation - From a QC Topic to a Market-Access Problem
28.05.2026WHO Working Document on Bioequivalence open for Public Consultation


